Rejection, Transplant Withdrawn Phase 2 Trials for Immune Globulin Human (DB00028)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01035593Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal TransplantationTreatment